I Just Want to Be a Quiet Top Student

Chapter 648 So fictitious

After answering the interview questions of the reporters from People’s Big News, Shen Qi accepted interviews from several other media, both domestic and foreign.

One media asked: “Professor Shen, you mentioned in the report that the research results of macrocyclic compounds are reflected in practical applications. A new class of macrocyclic compounds, triazaoctenes, has been synthesized. We are in the CFDA According to the official announcement, triazaoctene has been approved to enter the phase I clinical trial.”

Shen Qi: “Yes.”

Media: “We learned that your wife, as a subject, participated in the phase I clinical trial of triazaoctene. Is this true?”

Shen Qi: “Yes.”

Wow

Huh?

The media friends on the scene made various voices.

Soon, relevant news reports will be online.

“On the second day of the IUPAC World Chemistry Conference, Academician Shen Qi first publicly reported the research progress of “Macrocyclic Compounds, New Rearrangement Reactions and Related Chemical Drug Applications”, which aroused enthusiastic responses.”

“According to domestic and foreign chemists, the research results of Shen Qi’s team are expected to win this year’s Nobel Prize in Chemistry.”

“The actual product of “Macrocyclic Compounds, New Rearrangement Reactions and Related Chemical Drug Applications” is a chemical drug called triazaoctene, which is currently in phase I clinical trials in China, Mrs. Shen Qi As a subject, I am participating in clinical trials.”

The media reports were fairly objective. They reported the facts by stating the facts.

The comments and messages are varied.

“Take a wife to do a human test?”

“Can’t afford to offend.”

“I believe Academician Shen must have enough confidence to do this.”

“In fact, Academician Shen did this scientific research project to cure his wife’s disease, and then accidentally won a Novo Prize…”

“Don’t make trouble, although R anemia is a rare disease, the patient is not only Mrs. Shen. Academician Shen did this to save patients all over the world.”

“No matter what, I wish Academician Shen’s scientific research project success, and I wish patients all over the world recover.”

……

At two o’clock in the afternoon, Shen Qi hosted a Q&A meeting on “Macrocyclic Compounds, New Rearrangement Reactions and Related Chemical Drug Applications” in Conference Hall 2 of the Capital International Convention Center.

The No. 2 Conference Hall, which can accommodate more than 80 people, is full of seats. Some late-arriving scholars can only stand, and the total number of people present exceeds a hundred.

This IUPAC World Chemistry Conference has more than a thousand participants. Scholars with a little fame and a little bit of things, there are only a hundred people, almost all of them are here.

“Everyone, you can ask questions,” Shen Qi said.

The first question was a white scholar: “Hello Professor Shen, I’m Charlie Manson from Caltech. The macrocyclic compound of the structure of triazaoctene meets the theoretical system of macrocyclic compounds that you have constructed. But we all know that there are many kinds of known and unknown macrocyclic compounds. How can you ensure that your theory can be adapted to all or most of the macrocyclic compounds?”

This question is very good. It speaks the voice of most participants. It is a representative question.

Shen Qi replied: “The method I used is very traditional. I get theories through experiments, and then put them into experiments for verification. Mr. Manson is right. How can I prove that my theories can fit all or most of them? Macrocyclic compounds? Experiment, yes, experiment.”

“The paper “Macrocyclic Compounds, New Rearrangement Reactions and Application of Related Chemical Drugs” has been published. It can be said that our team has unreservedly demonstrated the theoretical system, reaction mechanism, and practical application cases we know. Come out. It is impossible for our laboratory to verify all macrocyclic compounds, so please help us to verify.”

“If a research team happens to be studying macrocyclic compounds, then I hope that our “Macrocyclic Compounds, New Rearrangement Reactions and Application of Related Chemical Drugs” can be helpful to your experiments, or be proven to be wrong . Thank you, next one.”

Scholars at the meeting asked questions one after another, and Shen Qi answered them one by one.

The Q&A meeting went very smoothly, and everyone had friendly exchanges and harmonious discussions.

Two hours passed quickly, and most scholars were satisfied with Shen Qi’s answers to various questions.

Actually, Shen Qi has been waiting for someone’s question, Mr. Orange.

However, Mr. Tachibana didn’t seem to come to the Q&A meeting.

The five-day IUPAC World Chemistry Conference is over. “Macrocyclic compounds, new rearrangement reactions and applications of related chemical drugs” are officially published in the conference proceedings for scholars from all over the world to study and verify.

Shen Qi’s chemistry level still has not been upgraded to level 14.

“Maybe it is necessary to wait for scholars all over the world to verify that OK is OK before I can upgrade to level 14?” Shen Qi had a brief communication with the system.

There is no response from the system.

Yan Great People’s Hospital.

The 　　 triazaoctene clinical trial research team has started to administer drugs to subjects including Ou Ye.

Under normal circumstances, drugs are not expected to achieve any clinical efficacy in phase I clinical trials. When conducting Phase I clinical trials, the main consideration is the safety, rights, and health of the subjects, as well as the scientific information that can be obtained from the clinical trials.

The first phase I clinical trial does is the tolerance test to get the dose range that the human body can tolerate the new drug.

In the tolerance test, Ou Ye’s daily routine is to take medicine, do electrocardiogram, blood/urine routine, liver and kidney function biochemical test, RBC, HCT, etc., every day, it is very regular.

During this time, Shen Qi’s focus of work and life is in the hospital. He pays close attention to all the data and details of the phase I clinical trial of triazaoctene.

Shen Qi carefully studied the test data of all subjects from the first day to today, and focused on the test data of Ou Ye.

“The routine examination was normal, and there were no abnormalities in RBC, HCT, hemoglobin concentration, and blood creatinine. If there is no abnormality, it is good news. Wife, how do you feel about yourself?”

“I…I feel so empty…”

“This is a normal reaction. If you change to a healthy volunteer, you will take medicine every day and do so many tests. It will be false. I analyzed your test data and your indicators are the same as before, and they have not deteriorated. No improvement. In fact, it is difficult for the research doctor and me to judge the efficacy of triazaoctene on patients during the tolerability test. The only judgment we can make is that the drug is safe and the patient can withstand the dose How much is it, and so on. Again, no exception is good news.”

“Hmm…I know…I will stick to it…Nophie, is Nophie okay? Does Nophie miss me?”